Learn more

THE CHILDREN'S HOSPITAL OF PHILADELPHIA

Overview
  • Total Patents
    95
  • GoodIP Patent Rank
    17,538
  • Filing trend
    ⇩ 100.0%
About

THE CHILDREN'S HOSPITAL OF PHILADELPHIA has a total of 95 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CHILDRENS HOSPITAL PHILADELPHIA, PHILADELPHIA CHILDREN HOSPITAL and SHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES.

Patent filings per year

Chart showing THE CHILDREN'S HOSPITAL OF PHILADELPHIAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hakonarson Hakon 20
#2 Kao Charlly 13
#3 High Katherine A 12
#4 Glessner Joseph 7
#5 Flake Alan 7
#6 Levy Robert J 6
#7 Camire Rodney M 6
#8 Davey Marcus 6
#9 Wenger Tara 5
#10 Wu Zhi-Liang 5

Latest patents

Publication Filing date Title
CA3089597A1 Biometric sensor device for digital quantitative phenotyping
US2020261675A1 Automatic detection of airway device, endotracheal intubation, and tube misplacement in children during the anesthesia procedure
US2020248161A1 Compositions and Methods for Modulating Factor IX Function
WO2017223385A1 Protein vii fragments and methods of use thereof for the treatment of inflammatory disorders
WO2017161273A1 Therapeutic for treatment of diseases including the central nervous system
WO2017123961A1 Factor viii variants, nucleic acid sequences, and methods and uses for treatment of hemostasis disorders
CA2989857A1 Method and apparatus for extracorporeal support of premature fetus
WO2016201438A1 New targets modulated by a casual variant of type 2 diabetes (t2d) embedded within the tcf7l2 gene and methods of use thereof for identifying agents having efficacy for the treatment of type 2 diabetes and other metabolic disorders
WO2016144637A1 Tocopheryloxyacetate ester-based co-drug conjugates
US2017239294A1 Compositions and methods for treating b-lymphoid malignancies
CA2959624A1 Compositions and methods for the inhibition of chondrogenesis
KR20170084012A An improved expression cassette for packaging and expression of variant factor viii for the treatment of hemostasis disorders
US2017083664A1 Methods of Diagnosing and Treating Autism
KR20170016363A Portable surgical methods, systems, and apparatus
EP3113777A1 Methods for managing care of patients predisposed to progressive mitral valve diseases
CN106687144A Compositions and methods for treating liver injury
US2016235824A1 Compositions and Methods for Increasing the Half-Life of Factor XA
EP2968724A1 Extracorporeal life support system and methods of use thereof
CA2744174A1 Snake factor v and methods of use as a procoagulant
EP2291544A2 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes